The Indonesia glucose monitoring device market is anticipated to witness an impressive growth during the forecast period. This can be ascribed to the growing awareness of diabetes management, particularly in urban areas. This has led to an increased demand for glucose monitoring devices and other diabetes management tools, as patients seek to better understand and manage their condition. Healthcare expenditure in Indonesia is increasing, driven by factors such as economic growth and government efforts to improve healthcare access. This has led to increased investment in healthcare infrastructure, including the development and distribution of glucose monitoring devices. The Indonesian government has implemented several policies and initiatives aimed at improving diabetes management and reducing the burden of diabetes in the country. These initiatives include increasing funding for diabetes prevention and treatment programs, promoting healthy lifestyle.
Advances in technology have led to the development of more advanced glucose monitoring devices, including non-invasive devices and those that are connected to mobile apps and other digital platforms. These devices are becoming increasingly popular in Indonesia, as they offer more convenient and personalized diabetes management solutions. Partnerships and collaborations between healthcare companies, government organizations, and other stakeholders are driving innovation and improving access to glucose monitoring devices in Indonesia. These partnerships are helping to address challenges such as affordability and accessibility and are driving growth in the market. The adoption of digital health technologies is growing rapidly in Indonesia, driven by increased smartphone penetration and internet connectivity. Glucose monitoring devices that are connected to mobile apps or other digital platforms are becoming more popular, as they allow patients to track their glucose levels more easily and receive real-time feedback on their diabetes management.
Developments in Glucose Monitoring Device
There have been several advancements in glucose monitoring devices in recent years, which have improved the accuracy, convenience, and ease of use of these devices. They are primarily used by people with diabetes to monitor their blood glucose levels and adjust their treatment accordingly. Glucose monitoring devices come in different types, including blood glucose meters, continuous glucose monitors (CGMs), and flash glucose monitoring systems. Blood glucose meters are portable devices that allow individuals to check their blood glucose levels by pricking their finger with a lancet and placing a small amount of blood on a test strip. The test strip is then inserted into the meter, which measures the amount of glucose in the blood sample and displays the result. Continuous glucose monitoring (CGM) systems are medical devices that are used to monitor glucose levels in the interstitial fluid (fluid that surrounds the cells in the body) on a continuous basis. Continuous glucose monitoring systems consist of a small sensor that is inserted under the skin, usually on the abdomen or arm. The sensor measures glucose levels in the interstitial fluid every few minutes and sends this data wirelessly to a receiver or smartphone app. The receiver or app displays the glucose readings in real-time and provides alerts for high or low glucose levels.
Continuous glucose monitoring systems provide several advantages over traditional glucose monitoring methods, such as fingerstick blood glucose testing. They provide continuous, real-time glucose data, which can help individuals with diabetes to make informed decisions about their treatment, including adjusting their medication, diet, and exercise routine. Continuous glucose monitoring systems can also help to identify trends in glucose levels over time, which can be useful for optimizing diabetes management. Indonesia continuous glucose monitors segment is predicted to expand at a CAGR of 16.93%, from USD 0.984 million in 2021 to USD 2.941 million by 2028. Flash glucose monitoring (FGM) systems are a type of glucose monitoring device used by people with diabetes to measure their glucose levels without the need for frequent fingerstick blood glucose testing. Flash glucose monitoring systems consist of a small sensor worn on the skin that continuously measures glucose levels in the interstitial fluid, which is the fluid that surrounds the cells in the body. One of the main advantages of FGM systems is that they do not require fingerstick blood glucose testing, which can be painful and inconvenient. FGM systems also provide a more discreet and convenient option for glucose monitoring. This factor will accelerate the growth of Indonesia glucose monitoring device market.
Increase in Utilization of Insulin Pumps
Insulin pumps are small, computerized devices that are used to deliver insulin to people with diabetes. They are typically worn on the body and can provide continuous or on-demand delivery of insulin, depending on the user's needs. Insulin pumps have become increasingly popular in recent years, as more people with diabetes are seeking alternative treatment options to traditional insulin injections. One of the main advantages of insulin pumps is that they can provide more precise control of insulin delivery compared to injections. This can help to reduce the risk of high or low blood sugar levels, which can lead to complications such as diabetic ketoacidosis or hypoglycemia. Insulin pumps can also provide greater flexibility in terms of dosing, timing, and mealtime insulin delivery, which can help to improve quality of life for people with diabetes. There has been a growing trend in recent years towards the use of insulin pumps, both in Indonesia and globally. This can be attributed to several factors, including increased awareness of the benefits of insulin pumps, advances in pump technology, and improvements in reimbursement policies. Additionally, as more people are diagnosed with diabetes at a younger age, there is a greater need for effective and convenient treatment options that can be integrated into daily life. This factor will help in the increment of Indonesia glucose monitoring device market.
Increase in Geriatric Population
The geriatric population is expected to increase in the coming years due to a combination of factors such as improving healthcare, better nutrition, and increased life expectancy. As the geriatric population grows, so will the number of individuals with diabetes, and this is likely to increase the demand for glucose monitoring devices in the country. Furthermore, older adults often have other medical conditions and may be taking multiple medications, which can complicate their diabetes management. Therefore, accurate glucose monitoring is crucial for older adults with diabetes to help prevent complications and improve their overall health outcomes. On top of that, the increasing geriatric population in Indonesia is also expected to drive the development of new and innovative glucose monitoring devices that are tailored to the needs and preferences of older adults. For example, devices that are more user-friendly, have larger displays, and require less manual dexterity may be developed to better meet the needs of older adults. Therefore, the growing geriatric population in Indonesia is expected to have a significant impact on the demand for glucose monitoring devices in the country.
Recent Developments
In 2021: Indonesia-based medical device company PT Hexpharm Jaya Laboratories announced the launch of its new glucose monitoring device, G-Check. The device offers features such as real-time glucose monitoring and mobile app integration and is aimed at providing patients with more affordable and accessible diabetes management solutions.
In 2021: Medisave Pharmacy, a leading pharmacy chain in Indonesia, announced a partnership with Roche Diabetes Care to offer patients access to Roche's Accu-Chek glucose monitoring devices and diabetes management solutions. The partnership aimed to improve access to diabetes care for patients in Indonesia.
In 2021: PT Semeru Teknik, an Indonesian medical device company, launched a new glucose monitoring device called Glucotek. The device is designed to be affordable and accessible to patients in Indonesia and offers features such as non-invasive glucose monitoring and cloud-based data management.
Download Free Sample Report
Market Segmentation
Indonesia glucose monitoring device market can be segmented into by product type, component, application, end user, and by region. By product type, Indonesia glucose monitoring device market can be segmented into self-monitoring glucose devices and continuous glucose monitoring devices. By component, Indonesia glucose monitoring device market can be segmented into glucometer, test strips, lancets, insulin pumps, others. By application, Indonesia glucose monitoring device market can be segmented into type 1 diabetes, type 2 diabetes, and gestational diabetes. By end user, Indonesia glucose monitoring device market can be segmented into home care settings, hospital, and others. By region, Indonesia glucose monitoring device market can be segmented into Java, Sumatra, Kalimantan, and Bali.
Market Players
PT Glucovation Medtech, PT Alkes Medika Indonesia, PT Jakarta Medical System, PT Arkray, B Braun Melsungen AG, PT Medtronic Indonesia, and PT Abbott Indonesia are some of the market players in Indonesia glucose monitoring device market.
|
Attribute
|
Details
|
|
Base
Year
|
2022
|
|
Historic
Data
|
2018 – 2022
|
|
Estimated
Year
|
2023
|
|
Forecast
Period
|
2024 – 2028
|
|
Quantitative
Units
|
Revenue in USD Million, and CAGR for 2018-2022 and 2024-2028
|
|
Report
Coverage
|
Revenue
forecast, company share, competitive landscape, growth factors, and trends
|
|
Segments
Covered
|
Product
Type
Component
Application
End
User
|
|
Regional
Scope
|
Java,
Sumatra, Kalimantan, Bali
|
|
Key
Companies Profiled
|
PT
Glucovation Medtech, PT Alkes Medika Indonesia, PT Jakarta Medical System, PT
Arkray, B Braun Melsungen AG, PT
Medtronic Indonesia, PT Abbott Indonesia
|
|
Customization
Scope
|
10%
free report customization with purchase. Addition or alteration to country,
regional & segment scope.
|
|
Pricing
and Purchase Options
|
Avail customized purchase options to meet your exact research
needs. Explore purchase options
|
|
Delivery
Format
|
PDF and Excel through
Email (We can also provide the editable version of the report in PPT/Word
format on special request)
|
Report
Scope:
In this report,
the Indonesia glucose monitoring device market has been segmented into the
following categories, in addition to the industry trends which have also been
detailed below:
- Indonesia Glucose Monitoring Device
Market, By Product Type:
o
Self-Monitoring
Glucose Devices
o
Continuous
Glucose Monitoring Devices
- Indonesia Glucose Monitoring Device
Market, By Component:
o
Glucometer
o
Test
Strips
o
Lancets
o
Insulin
Pumps
- Indonesia Glucose Monitoring Device Market, By Application:
o
Type
1 Diabetes
o
Type
2 Diabetes
o
Gestational
Diabetes
- Indonesia Glucose Monitoring Device
Market, By End User:
o
Home
Care Settings
o
Hospital
- Indonesia Glucose Monitoring Device Market, By Region:
o
Java
o
Sumatra
o
Kalimantan
o
Bali
Competitive
Landscape
Company
Profiles: Detailed
analysis of the major companies present Indonesia glucose monitoring device
market.
Available
Customizations:
With the given
market data, TechSci Research offers customizations according to a company’s
specific needs. The following customization options are available for the
report:
Company
Information
- Detailed analysis and profiling of
additional market players (up to five).
Indonesia
glucose monitoring device market is an upcoming report to be released soon. If
you wish an early delivery of this report or want to confirm the date of
release, please contact us at
[email protected]